Patrick Foong

Regenerative clinics: strong language from FDA

Patrick Foong | 8 Aug 2020 |

tags: stem cell therapies

American regulators get tough

---

Covid-19: should we deliberately infect volunteers?

Patrick Foong | 2 Aug 2020 |

tags: coronavirus, research ethics

A thorny question for researchers and ethicists

---

Unscrupulous scammers are selling stem cell therapies for Covid-19

Patrick Foong | 14 Jun 2020 |

tags: stem cell therapies

Regulatory agencies need to be tough

---

Ethical issues surrounding egg donation in genome editing 

Patrick Foong | 11 Jan 2020 |

tags:

Women need adequate counselling

How should chimeric embryo research be regulated?

Patrick Foong | 25 Aug 2019 |

tags: chimeras, stem cell research

Amazingly, recent experiments fall between regulatory stools in Australia

---

Fertility tourism: Australians travelling to US to have ‘designer babies’

Patrick Foong | 8 Jun 2019 |

tags: australia, designer babies, ivf

It could become legal in Australia within a few years

---

The brave new world of human genome editing: an Australian perspective

Patrick Foong | 4 Feb 2019 |

tags: australia, gene editing

Australian law needs to catch up with scientific developments

---

‘Right to try’ bills passed in US Congress: more harm than good?

Patrick Foong | 14 Apr 2018 |

tags: right to try, United States

The FDA has a real role to play and should not be sidelined

---

Untested stem cell therapies finally drawing attention of Australian regulators

Patrick Foong | 24 Nov 2017 |

tags: stem cell ethics, stem cell therapies, stem cells

There has already been one death in a clinic